Trupanion, Inc. $TRUP Shares Purchased by Versor Investments LP

Key Points

• Versor Investments LP increased its stake in Trupanion, Inc. by 321.4% in the first quarter, owning about 0.07% of the company worth approximately $1,099,000.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Trupanion, with an average price target of $54.17, reflecting expectations of growth despite a recent downgrade by Lake Street Capital.
• Insider activity saw CEO Margaret Tooth and CFO Fawwad Qureshi sell shares recently, with Tooth's sale representing a 3.26% decrease in her ownership, while a total of 11,562 shares valued at $544,870 were sold by insiders over the last quarter.

Versor Investments LP lifted its stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 321.4% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 29,500 shares of the financial services provider's stock after purchasing an additional 22,500 shares during the quarter. Versor Investments LP owned about 0.07% of Trupanion worth $1,099,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Palisade Capital Management LP raised its position in Trupanion by 36.7% during the first quarter. Palisade Capital Management LP now owns 244,354 shares of the financial services provider's stock worth $9,107,000 after acquiring an additional 65,653 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Trupanion by 112.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider's stock worth $13,204,000 after purchasing an additional 144,828 shares in the last quarter. Northern Trust Corp raised its position in shares of Trupanion by 9.0% during the 4th quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider's stock worth $17,749,000 after purchasing an additional 30,549 shares during the last quarter. Balyasny Asset Management L.P. lifted its stake in Trupanion by 368.2% in the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock valued at $40,548,000 after buying an additional 661,559 shares in the last quarter. Finally, Banque Pictet & Cie SA acquired a new stake in Trupanion during the 1st quarter valued at $439,000.

Wall Street Analyst Weigh In

TRUP has been the topic of a number of recent research reports. Piper Sandler upped their target price on shares of Trupanion from $62.00 to $67.00 and gave the company an "overweight" rating in a report on Friday, August 8th. Lake Street Capital cut their price objective on Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a report on Friday, May 2nd. Stifel Nicolaus boosted their price objective on shares of Trupanion from $41.00 to $45.00 and gave the stock a "hold" rating in a research note on Friday, August 8th. Finally, Cantor Fitzgerald raised shares of Trupanion to a "hold" rating in a research note on Wednesday, August 13th. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $54.17.

Trupanion Stock Performance

TRUP traded down $0.23 during trading hours on Wednesday, hitting $47.75. 428,571 shares of the stock were exchanged, compared to its average volume of 568,183. The stock has a market cap of $2.05 billion, a price-to-earnings ratio of 183.66 and a beta of 1.78. The stock has a 50-day simple moving average of $51.05 and a 200-day simple moving average of $44.08. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.69 and a quick ratio of 1.69. Trupanion, Inc. has a 12 month low of $31.00 and a 12 month high of $57.90.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its earnings results on Thursday, August 7th. The financial services provider reported $0.22 earnings per share for the quarter, topping analysts' consensus estimates of ($0.03) by $0.25. Trupanion had a net margin of 0.81% and a return on equity of 3.31%. The company had revenue of $353.56 million for the quarter, compared to analysts' expectations of $346.73 million. During the same period in the prior year, the company earned ($0.14) earnings per share. The firm's revenue was up 12.3% compared to the same quarter last year. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Insider Buying and Selling at Trupanion

In other news, COO John R. Gallagher sold 4,000 shares of the company's stock in a transaction dated Thursday, May 29th. The shares were sold at an average price of $47.90, for a total transaction of $191,600.00. Following the completion of the transaction, the chief operating officer owned 26,966 shares in the company, valued at approximately $1,291,671.40. This represents a 12.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Fawwad Qureshi sold 2,534 shares of the firm's stock in a transaction that occurred on Thursday, May 29th. The shares were sold at an average price of $48.31, for a total transaction of $122,417.54. Following the completion of the sale, the chief financial officer owned 3,545 shares in the company, valued at $171,258.95. The trade was a 41.68% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 7,562 shares of company stock valued at $361,430. Corporate insiders own 5.42% of the company's stock.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.